INSR and cholangiocarcinoma: A recent study found that erlotinib-resistant CCA cells highly expressed insulin receptor (IR) and insulin-like growth factor (IGF) 1 receptor (IGF1R), and In vivo tumor formation model constructed from these resistant cells showed rich CAFs infiltration.